FLGT Fulgent Genetics
Fulgent Genetics earnings company data as of 4:47 AM ET 10/19
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 6 Nov | EPS | 1.00 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by FLGT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $291K sold by 1 insider outside a trading plan
- None no planned (10b5-1) sales
-
Jian Xie COOSale$291K 10,000 shares at $29.10 2.8% of stakeTraded Nov 19, 2025 Filed Nov 21, 2025
Also filed in the last 12 months, not counted as buying or selling: 52 share withholdings for taxes, 19 stock grants, 14 sales to cover taxes, and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 12 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K | 1.01,2.01,7.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.